SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-007254
Filing Date
2023-04-28
Accepted
2023-04-28 16:02:37
Documents
70
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q imgn-20230331x10q.htm   iXBRL 10-Q 999093
2 EX-10.1 imgn-20230331xex10d1.htm EX-10.1 660748
3 EX-10.2 imgn-20230331xex10d2.htm EX-10.2 1261381
4 EX-31.1 imgn-20230331xex31d1.htm EX-31.1 10920
5 EX-31.2 imgn-20230331xex31d2.htm EX-31.2 11006
6 EX-32 imgn-20230331xex32.htm EX-32 10062
  Complete submission text file 0001558370-23-007254.txt   7674182

Data Files

Seq Description Document Type Size
7 EX-101.SCH imgn-20230331.xsd EX-101.SCH 52406
8 EX-101.CAL imgn-20230331_cal.xml EX-101.CAL 34660
9 EX-101.DEF imgn-20230331_def.xml EX-101.DEF 241301
10 EX-101.LAB imgn-20230331_lab.xml EX-101.LAB 422517
11 EX-101.PRE imgn-20230331_pre.xml EX-101.PRE 355327
64 EXTRACTED XBRL INSTANCE DOCUMENT imgn-20230331x10q_htm.xml XML 774569
Mailing Address 830 WINTER ST WALTHAM MA 02451
Business Address 830 WINTER ST WALTHAM MA 02451 (781)895-0600
ImmunoGen, Inc. (Filer) CIK: 0000855654 (see all company filings)

IRS No.: 042726691 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-17999 | Film No.: 23865759
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences